Lifecore Biomedical Debt 2024

Lifecore Biomedical Aktienanalyse

What does Lifecore Biomedical do?

Landec Corp is a US-American company specialized in the development, manufacturing, and marketing of innovative products in the Agribusiness and Biotechnology sectors. It was founded in 1986 as a spin-off from the engineering faculty of Stanford University. The company follows a unique business model based on the integration of advanced technologies and biological processes. This aims to achieve sustainable agriculture that is both mindful of natural resources and achieves high yields. One of Landec's main divisions is the Fresh-Cut Products segment, where the company produces a variety of high-quality salads, vegetable, and fruit snacks that are distributed under the brand Eat Smart®. These products are known for their freshness, taste, and healthy nutritional values, and have gained high recognition in the USA. Another important business division of Landec is the Apio Packaging segment, specialized in the manufacturing and marketing of innovative packaging solutions for fresh fruits and vegetables. The packaging, distributed under the brand BreatheWay®, is equipped with a unique technology that regulates gas exchange within the package and extends the shelf life of the contents. In addition to these core segments, Landec is also active in the field of Biotechnology. Here, the company develops innovative products and technologies for use in human healthcare as well as the agricultural industry. An example of this is Apio's recently introduced whole plant juice called GreenWise™. Landec Corp is known for its innovation capabilities and its ability to develop new products and technologies. Throughout its history, the company has acquired a number of patents and awards and constantly strives to improve and advance its products. Overall, Landec Corp is a company that focuses on sustainability, innovation, and quality. With its unique business model and wide range of products and services, the company is well-positioned to continue growing and expanding its leadership position in the agriculture and biotechnology industry. Lifecore Biomedical ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Lifecore Biomedical's Debt Structure

Lifecore Biomedical's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Lifecore Biomedical's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Lifecore Biomedical’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Lifecore Biomedical’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Lifecore Biomedical stock

What is the debt of Lifecore Biomedical this year?

Lifecore Biomedical has a debt level of 85.89 USD this year.

What was the debt of Lifecore Biomedical compared to the previous year?

The debt of Lifecore Biomedical has increased by -38.61% compared to the previous year dropped.

What are the consequences of high debt for investors in Lifecore Biomedical?

High debt can pose a risk for investors of Lifecore Biomedical, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Lifecore Biomedical?

Low debt means that Lifecore Biomedical has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Lifecore Biomedical affect the company?

An increase in debt of Lifecore Biomedical can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Lifecore Biomedical affect the company?

A reduction in debt of Lifecore Biomedical can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Lifecore Biomedical?

Some factors that can influence the debt of Lifecore Biomedical include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Lifecore Biomedical so important for investors?

The debts of Lifecore Biomedical are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Lifecore Biomedical take to change the debt?

To change the debt, Lifecore Biomedical can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Lifecore Biomedical pay?

Over the past 12 months, Lifecore Biomedical paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Lifecore Biomedical is expected to pay a dividend of 0 USD.

What is the dividend yield of Lifecore Biomedical?

The current dividend yield of Lifecore Biomedical is .

When does Lifecore Biomedical pay dividends?

Lifecore Biomedical pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Lifecore Biomedical?

Lifecore Biomedical paid dividends every year for the past 0 years.

What is the dividend of Lifecore Biomedical?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Lifecore Biomedical located?

Lifecore Biomedical is assigned to the 'Non-cyclical consumption' sector.

Wann musste ich die Aktien von Lifecore Biomedical kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Lifecore Biomedical from 7/4/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/4/2024.

When did Lifecore Biomedical pay the last dividend?

The last dividend was paid out on 7/4/2024.

What was the dividend of Lifecore Biomedical in the year 2023?

In the year 2023, Lifecore Biomedical distributed 0 USD as dividends.

In which currency does Lifecore Biomedical pay out the dividend?

The dividends of Lifecore Biomedical are distributed in USD.